Will third-party medical inspection agencies cut into the personal nucleic acid detection C-side business will become a new engine of growth?

Text . . . Yan han
with the gradual dispersal of the epidemic, in order to the safety of enterprises to resume work, but also corresponding to the needs of personal health testing, from April, provinces and cities have been open to individuals and social groups of the new crown virus nucleic acid testing. According to the list published by the provinces and cities, medical institutions still occupy the majority, but at the same time, a large number of third-party medical institutions have been approved to provide nucleic acid testing directly to the public.
So in the post-epidemic era, the list published in various places shows what kind of third-party medical examination pattern? Can a third-party medical inspection institution that has received a c-side testing requirement take another step along the direction of the C-side service? What kind of synergy can the Internet hospital, which is hot in the outbreak, have with third-party medical examination? The arterial network was analyzed for third-party medical examination in nucleic acid testing.
in the need to resume work and resume school, in order to further control the spread of the epidemic, different provinces for the detection of nucleic acid of the new coronavirus implemented different management methods. Individuals, units and schools have some new crown testing needs.
artery network statistics the current provinces and cities in the country to provide new coronavirus nucleic acid testing of the list of third-party medical institutions, and with public medical institutions and the CDC compared. From the provincial administrative regions and some provincial capital cities that have published the list so far, we can basically understand the distribution of third-party medical examination in China.
current arterial network statistics to the domestic provinces and cities are providing individual new coronavirus nucleic acid testing of various institutions, the third-party medical examination agencies only about 10%, the remaining 90% are public hospitals, local CDC and so on. Compared with medical institutions, the number of third-party medical institutions is still relatively low. But third-party medical inspection institutions are more powerful, each institution's maximum daily test ingrescans can reach hundreds to thousands. In the provision of nucleic acid testing services to the public at the same time, but also to undertake the hospital out of the medical testing needs, is the outbreak of the new crown virus nucleic acid testing force.
only from the number of laboratories allowed to provide individual nucleic acid testing, the third-party medical examination institutions more obviously divided into three echelons. The enterprises of the first echelon have basically completed the distribution of business covering the whole country, the enterprises of the second echelon have formed a preliminary chain size, which has some influence in some provinces and cities, and the third echelon has only 1-2 laboratories, basically in a single point of operation.
in the past, every mention of the third-party medical examination market, will be Golden Domain Medicine, Dean Diagnostics, Aedicon and Daan Gene as the four leading companies.
Golden Domain Medicine as the domestic third-party medical examination of the leading enterprises still firmly in the top, covering almost all provincial administrative districts in the country, Dean's diagnosis followed closely, coverage of more than 80%;
the main cut into the market of Daan Gene itself is the supply of medical test-related reagents, consumables and equipment, its third-party diagnostic business is mainly concentrated in the subsidiary Ofson Health, and in the second half of 2018, Yunkang Health's other shareholders reached a "unanimous action agreement." Although it remains the largest shareholder of Yunkang Health, it is no longer a controlling shareholder. Therefore, we can not understand the operation of Yunkang Health for nearly two years. However, according to this statistical list, Yunkang Health in the field of third-party medical examination services in the second echelon, and the first echelon has a certain gap.
the first echelon of this list also includes Kepu Bio's medical diagnostic business, Kepu Medical Examination and Huada Gene.
Cap's revenue reached 80 million in 2019, an increase of more than 80 percent from 2018, which is already a relatively fast pace of growth. The outbreak has been a catalyst for its development, with Kep's total revenue of about $78.36 million in the first quarter of 2020 alone, close to its full-year 2019 revenue. CapBio could be the biggest winner in this outbreak for third-party medical companies.
Huada Gene is a recognized leader in the field of special inspection, especially in the field of genetic testing. In this new crown outbreak, Huada Gene has 10 laboratories located throughout the country to provide related services, showing a strong regional coverage capacity.
second echelon in addition to Yunkang health, including a thousand wheat medical, Huayin health, Boao testing, everyone testing, Ping An good medical (Ping An Health (testing) center under the testing business) and so on. Only from the coverage point of view, although the second echelon of enterprises and the first echelon of the enterprise still has a relatively large gap, but has formed a chain scale, covering a number of provincial administrative regions.
after the second tier, there are a large number of independently operated third-party medical inspection agencies scattered throughout the country. The total number of third-party testing laboratories in these areas exceeds even the sum of the first and second tiers. Although resources continue to be pooled towards the head, these scattered third-party medical institutions still constitute the largest group of enterprises in third-party medical institutions.
Although third-party medical examination in the outbreak shared the demand for nucleic acid testing of public medical institutions, but due to the outbreak of a large number of hospital routine medical treatment business stopped, third-party medical examination in the regular project revenue significantly reduced. Under the influence of a positive and negative two-way, the third-party medical examination industry in the outbreak of how on the way?
this, we can explore the financial performance of leading companies. Golden Domain Medical, which has the largest market share, has reported its first-quarter 2020 results. Its first-quarter revenue was essentially unchanged from 2019, and its profit ratio was flat. So while we've seen cases like Cape Medical Examination actually pay dividends in the outbreak, the two-way impact of the outbreak on the revenue of third-party medical inspection companies is almost negative and negative, and the third-party medical examination industry is on par with previous years.
but the financial performance is only one aspect, personal nucleic acid testing services for third-party medical examination opened a new flow intake, is its unexpected joy in the outbreak. In the past, the clients of third-party medical examination were mainly hospital inspection departments. Third-party medical examination to undertake the hospital's examination needs, for patients directly to provide services to the main body is still the hospital. In this new crown outbreak, the third-party medical examination institutions were approved to provide the new coronavirus nucleic acid testing services directly to individuals or social groups, the middle does not pass through the hospital, equivalent to opening up the C-side of the flow of the entrance.
Is it possible for third-party medical examinations to take advantage of this opportunity to continue to provide medical testing services to the public? We can analyze this problem in terms of service continuity, the degree to which user needs are matched.
from the service continuity point of view, the detection of nucleic acid of the new coronavirus itself is almost impossible to become normal development. The demand for this business will gradually diminish as the outbreak subsides. Third-party medical examination wants to carry out C-side business for a long time, and needs new service content to replace the new coronavirus nucleic acid testing. Is there the right service content? This involves the analysis of the other two dimensions.
can third-party medical examination meet the needs of C-side users? The mere testing needs can certainly be met, but most of the medical tests carried out by patient-based C-side users are conducted under the guidance of a doctor. Patients can almost only learn through the hospital what they are going to do. Medical tests, on the other hand, require a type of specimen, such as blood or puncture samples, that are not suitable for the patient to collect at home. This also makes patients more likely to go to the hospital for medical testing. In other words, third-party medical institutions are difficult to meet the needs of patients in the selection and sampling of test items. These needs still need to be provided by medically qualified medical institutions.
the speciality of the new coronavirus nucleic acid test. The C-side is from its own health and safety point of view, has produced a new crown virus detection needs. The list of institutions issued by the provinces and cities, guide the C end to the third-party medical inspection institutions for inspection, which will be C-side customers to the third-party medical inspection institutions. And the results of the new coronavirus detection only negative or positive, C-side users almost understand the cost. This is why regulators dare to open up individuals to third-party medical inspection agencies for testing is an important reason.
in the way of service, third-party medical examination to the central laboratory as the core of the service system for the C-side users is not convenient. First of all, the distribution density of the central laboratory is not high, not suitable to undertake a wide range of C-side business, second, the central laboratory is often located in the edge of the city area, transportation is not convenient, third, the central laboratory does not have medical qualifications, can only produce relevant data and results of inspection, but can not finally give a medical diagnosis, so patients in the third-party medical examination institutions issued by the report, or consult professional medical institutions to obtain the final medical advice.
therefore, according to the above analysis, third-party medical examination want to directly engage in toC medical testing services, from the current situation, may be more difficult.
a senior third-party medical examiner also showed no optimism in a conversation with arterial network. And his perspective is more on the regulatory level: "The new crown outbreak is a serious public health incident, in this particular case, third-party medical inspection to carry out toC business, to help achieve 'willing inspection' is no problem." But the business needs to grow for a long time, and there are many regulatory and industry self-regulatory issues. "
first of all, this new crown outbreak countries in the emergency situation for third-party medical examination opened the green light. But after the outbreak, there is considerable uncertainty about whether the state will continue to open third-party medical testing laboratories to provide more testing services to the public without the intervention of medical institutions.
on the other hand is the self-discipline of the industry. Although several enterprises in the head have achieved large-scale operation, but a large number of third-party medical inspection agencies scattered throughout the country can be self-disciplined attitude to regulate their own behavior for a long time, whether there will be "indiscriminate inspection, exaggerated propaganda" and other industries chaos.
in fact, there are no clear regulations on third-party medical examination other than the acceptance of third-party independent medical laboratories by the State. The industry itself lacks binding organization and consensus. Third-party medical examination is currently mainly for hospital services. As professional medical practitioners, hospitals are able to make professional judgments about third-party medical examination agencies. However, the C-side user does not have such a judgment. In the long run, a large number of third-party medical inspection institutions in the tail, service capacity is uneven, may cause the decline of the credibility of the industry, for the development of the industry has a negative impact.
professional medical examination business is not easy to carry out to the C side, but third-party medical examination still want to try to cut into the C-side market. Therefore, in the C-side business, the third-party medical examination enterprises have in fact already begun to make their own attempts.
third-party medical examination to provide inspection items are mainly divided into general inspection and special inspection two categories. In the field of special examination, there have been more mature toC business model has been developed, such as personal genome testing, tumor susceptibility gene testing and so on. Some of the companies in this field are also involved in this new coronavirus nucleic acid test, such as reiperican biology and humans and the future.
this type of toC business collection is often saliva, feces, urine and other easy users can collect their own, and easy to save the type of samples. The company also customizes the collection container so that the sample can remain biologically active and essential during long-distance transportation. As a result, this class of enterprises only needs 1-2 central laboratories to process specimens from all over the country.
But because third-party testing laboratories do not have medical qualifications, their direct user-provided testing services can only stay in health management for the time being.
and in the field of general inspection, the head of the enterprise is also in their own C-side business expansion. The same area it tries to cut into is also health management. Golden Field Medicine and Dean's Diagnosis made the same choice in this regard, moving into the field of physical examination.
but in the specific business model, but the two have different logic. Golden Domain Medical chose to cooperate with financial insurance to do B2B2C door-to-door medical examination services, while Dean's diagnosis set up its own Dean health check-up, opening up a direct 2C medical examination business.
both companies were initially buzzing, but the results were not encouraging. Jinyuan Medical's health check-up business achieved revenue of only about 36 million yuan in 2019, down more than 50% from 2018. Dean's revenue performance was slightly better, still achieving revenue of more than $100 million in 2019, up 11.03 percent from 2018. But its gross margin is only 25.78 percent, and its stores have not continued to expand, remaining five in Zhejiang province. The data mean simply that the two third-party medical companies are strategically abandoning the field after initial attempts to examine the market.
this situation may be related to the complexity of the medical examination market itself. On the other hand, medical examination and third-party medical examination may also be somewhat inconsistent. Medical examination for the professional level of the inspection institutions is not high requirements, and requires a large amount of management costs. Third-party medical examination professional level is strong, low-cost testing of their own advantages are difficult to be reflected in this industry.
want to combine with their own business advantages, perhaps third-party medical examination or to find a way to find opportunities from a more professional medical examination direction.
hospital is the main customer of third-party medical examination, but the hospital itself will also have the examination department to provide the corresponding medical examination services; So is there a scenario where medical services and report interpretation canbe be provided, but cannot provide medical tests?
scene seems to be talking about Internet hospitals. The rapid development of Internet hospitals may be an excellent opportunity for third-party medical examinations.
since September 2018, Internet healthcare has reached another upsurge with the distribution of Internet hospital licenses, the establishment of online medical practices and the maturity of the health insurance payment system. According to the statistics of the artery network, the establishment of internet hospitals in February 2020 reached a record high of 65, the development of the epidemic to accelerate the construction of Internet hospitals, and during the outbreak for the C side to solve the chronic diagnosis and treatment, pneumonia counseling and other medical treatment problems.
the establishment of the Internet hospital of the physical hospital radiation range increased, cross-district, cross-city, cross-provincial patients can be through the Internet hospital for slow re-diagnosis. However, due to the differences in medical level sesame, the level of local medical examination conducted by patients in the process of re-diagnosis is uneven, and the judgment of online doctors may have a greater impact. This also provides an opportunity for third-party medical examination.
third-party medical examination institutions covering the whole country can undertake the medical testing needs generated in the course of Internet diagnosis and treatment, establish the corresponding team to conduct on-site sampling, and then send through cold chain logistics to the central laboratory for centralized testing. The inspection report issued can also be transmitted directly to the corresponding doctor responsible for the consultation while it is delivered to the patient.
such a business path can take advantage of third-party medical inspection. The national chain of third-party medical inspection agencies can achieve a wide range of testing services, and.